Clinical Trial Update: Talquetamab in Patients With Refractory Generalized Myasthenia Gravis [NA]

View source ↗

Summary

A clinical trial update indicates talquetamab is being studied in patients with refractory generalized myasthenia gravis, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Talquetamab (talquetamab)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Myasthenia Gravis (MG) | NA | Status: NOT_YET_RECRUITING